Supplier
Aculabs INC
Aculabs INC was paid $7.22M by Medicaid between Jan 2018 and Dec 2024, across 121 billing codes. Its largest line is P9604, Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge — 13% of everything it billed.
33Billing provider infoACULABS INC
EAST BRUNSWICK, NJ 08816
EAST BRUNSWICK, NJ 08816
33aNPI1093749087assigned 07/10/2006
33bProvider typePortable X-ray and/or Other Portable Diagnostic Imaging Supplier
28Total paid$7.22M
24GClaims2,349,149
24DCodes billed121
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Portable X-ray and/or Other Portable Diagnostic Imaging Supplier providers in New Jersey
Rank by total paid#1 of 10
Median peer was paid$19K
This provider vs. median382×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 167,120 | $712K | |
| 2019 | 179,992 | $854K | |
| 2020 | 338,920 | $1.28M | |
| 2021 | 417,677 | $1.78M | |
| 2022 | 392,004 | $936K | |
| 2023 | 448,352 | $835K | |
| 2024incomplete | 405,084 | $827K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 13% | 284,043 | 148,590 | $952K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 13% | 45,769 | 20,577 | $921K |
| 80053 | Comprehensive metabolic panel | 10% | 216,671 | 144,492 | $747K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.0% | 288,045 | 175,897 | $503K |
| 80048 | Basic metabolic panel (calcium, ionized) | 5.5% | 126,019 | 76,233 | $397K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 4.3% | 37,977 | 17,071 | $308K |
| 84443 | Thyroid stimulating hormone (TSH) | 4.2% | 63,477 | 53,511 | $301K |
| 80061 | Lipid panel | 3.6% | 54,783 | 47,376 | $257K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.3% | 23,747 | 20,496 | $241K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.2% | 5,723 | 2,501 | $232K |
| 80050 | General health panel | 2.1% | 7,467 | 6,815 | $154K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.1% | 63,596 | 54,748 | $154K |
109 more codes
| 82607 | 1.5% | 20,039 | $107K | |
| 80164 | 1.4% | 21,151 | $98K | |
| 83880 | 1.3% | 10,108 | $96K | |
| 85027 | 1.3% | 46,544 | $90K | |
| 87186 | 1.2% | 23,670 | $87K | |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 134,963 | $85K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.2% | 41,793 | $84K |
| 83735 | 1.0% | 38,060 | $74K | |
| 80177 | <1% | 11,622 | $69K | |
| S3601 | Emergency stat laboratory charge for patient who is homebound or residing in a nursing facility | <1% | 17,102 | $66K |
| 82746 | <1% | 13,875 | $62K | |
| 85610 | <1% | 46,715 | $62K | |
| 84439 | <1% | 18,973 | $56K | |
| 82728 | <1% | 11,447 | $56K | |
| 80202 | <1% | 8,219 | $54K | |
| 84134 | <1% | 8,993 | $54K | |
| 84153 | <1% | 6,033 | $53K | |
| S9529 | Routine venipuncture for collection of specimen(s), single home bound, nursing home, or skilled nursing facility patient | <1% | 73,162 | $44K |
| 86141 | <1% | 6,697 | $42K | |
| 83970 | <1% | 2,494 | $41K | |
| 80076 | <1% | 10,628 | $34K | |
| 84100 | <1% | 23,849 | $34K | |
| 87040 | <1% | 7,053 | $30K | |
| 81001 | <1% | 48,304 | $28K | |
| 87088 | <1% | 18,970 | $28K | |
| 87077 | <1% | 4,907 | $27K | |
| 87070 | <1% | 5,694 | $26K | |
| 82140 | <1% | 7,136 | $26K | |
| 80185 | <1% | 3,320 | $22K | |
| 83540 | <1% | 12,650 | $22K | |
| 84481 | <1% | 4,509 | $22K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 908 | $21K |
| 83550 | <1% | 8,946 | $20K | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 1,769 | $15K |
| 86140 | <1% | 10,365 | $15K | |
| 80178 | <1% | 3,086 | $15K | |
| 87324 | <1% | 3,534 | $15K | |
| 86803 | <1% | 1,654 | $14K | |
| 80184 | <1% | 1,933 | $14K | |
| 85652 | <1% | 16,527 | $14K | |
| 87340 | <1% | 1,777 | $12K | |
| 86704 | <1% | 1,594 | $12K | |
| 87205 | <1% | 5,440 | $11K | |
| 86769 | <1% | 592 | $10K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 397 | $9K |
| 80162 | <1% | 2,308 | $9K | |
| 82274 | <1% | 4,690 | $8K | |
| 84132 | <1% | 4,486 | $8K | |
| 82550 | <1% | 3,395 | $8K | |
| 82947 | <1% | 3,277 | $8K | |
| 80156 | <1% | 917 | $8K | |
| 82248 | <1% | 3,200 | $8K | |
| 85730 | <1% | 4,443 | $7K | |
| 84436 | <1% | 3,619 | $7K | |
| 86708 | <1% | 1,166 | $7K | |
| 84479 | <1% | 2,909 | $6K | |
| 84145 | <1% | 1,133 | $6K | |
| 84146 | <1% | 398 | $5K | |
| 87634 | <1% | 403 | $5K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 782 | $4K |
| 83690 | <1% | 1,968 | $4K | |
| 84550 | <1% | 3,849 | $4K | |
| 82150 | <1% | 1,817 | $4K | |
| 85379 | <1% | 2,521 | $4K | |
| 83718 | <1% | 541 | $4K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 237 | $3K |
| 84478 | <1% | 606 | $3K | |
| 86481 | <1% | 136 | $3K | |
| 82043 | <1% | 1,719 | $3K | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 115,630 | $3K |
| 80051 | <1% | 910 | $3K | |
| 85018 | <1% | 4,010 | $2K | |
| 85014 | <1% | 3,396 | $2K | |
| 82565 | <1% | 1,299 | $2K | |
| 82310 | <1% | 1,057 | $2K | |
| 84480 | <1% | 798 | $2K | |
| 82570 | <1% | 1,460 | $2K | |
| 86706 | <1% | 231 | $2K | |
| 84520 | <1% | 1,117 | $2K | |
| 84460 | <1% | 1,478 | $2K | |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | <1% | 170,144 | $2K |
| 83615 | <1% | 1,352 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 387 | $2K |
| 84295 | <1% | 703 | $1K | |
| 82040 | <1% | 1,628 | $1K | |
| 84450 | <1% | 1,412 | $1K | |
| 82374 | <1% | 606 | $1K | |
| 84075 | <1% | 537 | $1K | |
| 82435 | <1% | 600 | $984.47 | |
| 85045 | <1% | 882 | $941.88 | |
| 82465 | <1% | 627 | $931.03 | |
| 80069 | <1% | 407 | $911.00 | |
| 82105 | <1% | 110 | $884.52 | |
| 82247 | <1% | 517 | $797.65 | |
| 86592 | <1% | 737 | $749.65 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 346 | $728.45 |
| 84155 | <1% | 552 | $492.40 | |
| 82977 | <1% | 303 | $492.27 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 46 | $368.40 |
| 84156 | <1% | 400 | $281.43 | |
| 86317 | <1% | 34 | $248.31 | |
| 87807 | <1% | 60 | $187.47 | |
| 85651 | <1% | 146 | $184.89 | |
| 87449 | <1% | 12 | $79.56 | |
| 83605 | <1% | 37 | $76.61 | |
| 82378 | <1% | 17 | $49.26 | |
| 84484 | <1% | 12 | $32.41 | |
| 00000 | 0% | 12 | $0.00 | |
| 99058 | 0% | 98 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGUDAITIS, PETER (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Galaxy Mobile Diagnostics Services LLC | East Brunswick, NJ | $92.18 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.